C, E. (2019) “PREVALANE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS”, Journal of the ASEAN Federation of Endocrine Societies, 34, p. 21. doi: 10.15605/jafes.034.S29.